Changes in Patient-Reported Outcome Measures With a Technology-Supported Behavioral Lifestyle Intervention Among...

Area of Science:

• Health outcomes research
• Clinical trial methodology
• Patient-centered care

Background:

• Obesity and type 2 diabetes (T2D) are prevalent in the US, impacting quality of life.
• Patient-reported outcomes (PROs) are crucial for managing T2D, especially with comorbidities.
• Standard clinical measures may not fully capture patient health perceptions.

Purpose of the Study:

• To assess the feasibility of collecting Patient-Reported Outcome Measurement Information System (PROMIS) data.
• To preliminarily evaluate changes in PROMIS scores over time.
• To compare PROMIS scores with general US population data in overweight/obese T2D patients.

Main Methods:

• Pilot randomized controlled trial with overweight/obese T2D patients.
• Three arms: mobile health (mHealth), paper diary, and standard care control.
• PROMIS-57 and PROMIS-Global Health questionnaires administered at baseline, 3, and 6 months.

Main Results:

• 26 patients completed all questionnaires; predominantly African American (68%) and female (57%).
• No significant differences between groups, but intervention groups showed positive trends.
• Feasibility demonstrated by complete data collection across all participants.

Conclusions:

• PROMIS questionnaires are feasible for assessing T2D-related symptoms in overweight/obese individuals.
• PROMIS data can benchmark symptom management needs.
• Results support using PROMIS to evaluate intervention effectiveness in T2D care.